Perspective Therapeutics, Inc.
CATX· NYSE
Filed Sep 30, 2013 · 10-K · 92 days after period end · 0001144204-13-053136
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | $1.24M | $1.31M | $1.26M |
| Net Income | -$993.56K | -$1.21M | -$712.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Sep 30, 2013 · 92 d after period end